EpiBiologics emerges with $50m and protein degradation platform
The biotech is launched with an antibody-based protein degradation platform, with technology licensed from UCSF.
Source: biopharma-reporter.com
Stay updated with breaking news from Alaa Halawa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biotech is launched with an antibody-based protein degradation platform, with technology licensed from UCSF.
UAE’s state-owned sovereign wealth fund has invested more than $1.5 billion into digital health companies since 2018. The country has also partnered with Cleveland Clinic and Mayo Clinic.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!